Bath & Body Works (NYSE:BBWI) Price Target Raised to $39.00 at Piper Sandler

Bath & Body Works (NYSE:BBWI - Get Free Report) had its price target raised by analysts at Piper Sandler from $36.00 to $39.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. Piper Sandler's price objective would indicate a potential upside of 6.47% from the stock's current price.

A number of other brokerages have also weighed in on BBWI. Telsey Advisory Group restated an "outperform" rating and issued a $42.00 price objective on shares of Bath & Body Works in a report on Monday, November 25th. Barclays increased their price objective on Bath & Body Works from $28.00 to $34.00 and gave the company an "underweight" rating in a research report on Tuesday, November 26th. Morgan Stanley decreased their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating for the company in a report on Thursday, November 21st. JPMorgan Chase & Co. raised their target price on shares of Bath & Body Works from $35.00 to $39.00 and gave the stock a "neutral" rating in a report on Tuesday, November 26th. Finally, TD Cowen lifted their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a research report on Thursday, December 12th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $42.69.

Bath & Body Works Stock Down 2.8 %

Shares of BBWI stock traded down $1.07 during trading hours on Monday, hitting $36.63. 4,220,577 shares of the company's stock traded hands, compared to its average volume of 3,482,220. The stock's fifty day simple moving average is $34.96 and its two-hundred day simple moving average is $33.84. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99. The stock has a market cap of $7.93 billion, a price-to-earnings ratio of 8.93, a PEG ratio of 1.43 and a beta of 1.82.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.61 billion during the quarter, compared to analysts' expectations of $1.58 billion. During the same quarter in the previous year, the business earned $0.48 earnings per share. The firm's quarterly revenue was up 3.1% compared to the same quarter last year. On average, equities analysts forecast that Bath & Body Works will post 3.26 earnings per share for the current fiscal year.

Insider Buying and Selling at Bath & Body Works

In related news, CEO Gina Boswell bought 6,000 shares of the company's stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the transaction, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.27% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. True Wealth Design LLC lifted its position in Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after purchasing an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt grew its position in Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock worth $38,000 after acquiring an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works during the third quarter valued at approximately $39,000. TD Private Client Wealth LLC lifted its stake in shares of Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock valued at $54,000 after purchasing an additional 331 shares during the last quarter. Finally, Meeder Asset Management Inc. boosted its holdings in shares of Bath & Body Works by 480.3% in the 3rd quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company's stock worth $55,000 after purchasing an additional 1,436 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.